Literature DB >> 4762649

Proceedings: The absorption, excretion and metabolism of perhexiline maleate by the human.

G J Wright, G A Leeson, A V Zeiger, J F Lang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4762649

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  [Electron microscopic study of nerve, muscle and skin lesions induced by perhexiline maleate (author's transl)].

Authors:  J M Mussini; J J Hauw; R Escourolle
Journal:  Acta Neuropathol       Date:  1977-04-29       Impact factor: 17.088

Review 2.  Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.

Authors:  Andrew A Wolff; Heschi H Rotmensch; William C Stanley; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

3.  Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy.

Authors:  E Singlas; M A Goujet; P Simon
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

4.  Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state dose.

Authors:  Benedetta C Sallustio; Ian S Westley; Raymond G Morris
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

5.  N-dephenylated and N-phenyl urinary metabolites of mociprazine (CERM 3517) in beagle dogs after oral administration. A mass spectrometric determination.

Authors:  A Enreille; J F Pognat; M J Galmier; C Lartigue-Mattei; J L Chabard; N Busch; J A Berger
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Apr-Jun       Impact factor: 2.441

6.  Polymorphic hydroxylation of perhexiline maleate in man.

Authors:  R G Cooper; D A Evans; E J Whibley
Journal:  J Med Genet       Date:  1984-02       Impact factor: 6.318

7.  Studies on the metabolism of perhexiline in man.

Authors:  R G Cooper; D A Evans; A H Price
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Polymorphic hydroxylation of perhexiline in vitro.

Authors:  L B Sørensen; R N Sørensen; J O Miners; A A Somogyi; N Grgurinovich; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

Review 9.  Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.

Authors:  Sanja Dragovic; Nico P E Vermeulen; Helga H Gerets; Philip G Hewitt; Magnus Ingelman-Sundberg; B Kevin Park; Satu Juhila; Jan Snoeys; Richard J Weaver
Journal:  Arch Toxicol       Date:  2016-09-22       Impact factor: 5.153
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.